Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

22.0%

115 terminated/withdrawn out of 522 trials

Success Rate

68.7%

-17.9% vs industry average

Late-Stage Pipeline

11%

56 trials in Phase 3/4

Results Transparency

40%

102 of 252 completed trials have results

Key Signals

89 recruiting102 with results67 terminated48 withdrawn

Enrollment Performance

Analytics

N/A
217(57.0%)
Phase 1
51(13.4%)
Phase 2
43(11.3%)
Phase 4
40(10.5%)
Phase 3
16(4.2%)
Early Phase 1
14(3.7%)
381Total
N/A(217)
Phase 1(51)
Phase 2(43)
Phase 4(40)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (522)

Showing 20 of 522 trials
NCT06969755Phase 4Recruiting

Biomarkers to Enhance Early Schizophrenia Treatment

Role: lead

NCT07729228Not Yet Recruiting

Pulse Detection in Cardiac Arrest Patients Using a Doppler Ultrasound Patch on the Carotid Artery

Role: collaborator

NCT05570851Not ApplicableCompleted

Alcohol Cessation Among Head and Neck Cancer Survivors

Role: lead

NCT06486922Not ApplicableCompleted

Starting Early to Prevent Obesity Using Telehealth (StEP OUT): Intervention Development Trial

Role: lead

NCT07709117Not ApplicableNot Yet Recruiting

A Pilot Study to Improve Diabetes Management Through Family-Based Health Care Navigation

Role: collaborator

NCT07620262Not ApplicableRecruiting

Prospective Remapping With Concomitant Left Atrial Appendage Occlusion to Ensure Durable Electroporation Study

Role: lead

NCT02505074Completed

Natural History of Melody Valve in the Mitral and Tricuspid Position

Role: collaborator

NCT05730283Phase 2Recruiting

Prevention of Ototoxicity in NTM Patients Treated With IV Amikacin

Role: collaborator

NCT07703670Not ApplicableRecruiting

MicroRNAs as Biomarkers in First Episode Schizophrenia

Role: lead

NCT07250113Not ApplicableEnrolling By Invitation

WeCareToFeedDysphagia to Reduce Care-partner Burden Full-scale RCT

Role: lead

NCT06483139Completed

Novel Treatments in Improving Renal Outcomes in Light Chain Cast Nephropathy

Role: collaborator

NCT02822989Not ApplicableCompleted

Using the Cholinergic Anti-Inflammatory Pathway to Treat Systemic Lupus Musculoskeletal Pain

Role: lead

NCT07677579Phase 2Not Yet Recruiting

NIMBLE-CRC: NeoImmunoModulation Before Leveraging Excision in Colorectal Rectal Cancer

Role: lead

NCT07675174Phase 1Not Yet Recruiting

Phase I-II PTCy, Bortezomib and Sitagliptin for Prevention of GvHD Following Allogeneic HSCT

Role: lead

NCT06246149Phase 3Recruiting

Adjuvant Tebentafusp in High Risk Ocular Melanoma

Role: collaborator

NCT05273723Phase 1Completed

A BCT Intervention for Physical Activity Among Individuals on Statins

Role: lead

NCT07122466Active Not Recruiting

Early Treatment ctDNA Dynamics to Predict Response to Chemotherapy

Role: lead

NCT07193862Early Phase 1Recruiting

Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Colorectal Liver Metastasis

Role: lead

NCT06836050Completed

IPV and Lung Compliance in Invasively Ventilated Children

Role: lead

NCT05544903Completed

Point of Care Ultrasound to Predict Intensive Care Unit Admission of Patients Presenting With Sepsis to the Emergency Department

Role: lead